Literature DB >> 6979593

Resistance to cefamandole: derepression of beta-lactamases by cefoxitin and mutation in Enterobacter cloacae.

T D Gootz, C C Sanders, R V Goering.   

Abstract

Studies were performed to characterize resistance to cefamandole in two strains of Enterobacter cloacae. Susceptible wild-type cells were exposed either to cefamandole to select stably resistant mutants or to cefoxitin to induce unstable resistance. The two types of resistant cells inactivated cefamandole, and their beta-lactamases had identical isoelectric focusing patterns and substrate profiles. Studies of the beta-lactamases of these resistant cells indicated that the enzymes belonged to the Richmond and Sykes Group I and suggested that their production in wild-type cells is under repressor control. The resistant mutants appeared to be stably derepressed at the locus for beta-lactamase expression, whereas cefoxitin-induced cells were reversibly derepressed wild-type cells. Transfer of plasmids from one mutant colony to recipient Escherichia coli cells did not transfer resistance. These two types of resistance to cefamandole may explain the widely discrepant results obtained during in vitro and in vivo studies, as well as the rapid emergence of resistance that has been observed during clinical use.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6979593     DOI: 10.1093/infdis/146.1.34

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  39 in total

1.  An Automated Miniaturized Method to Perform and Analyze Antimicrobial Drug Synergy Assays.

Authors:  Peter Chase; Imarhia Enogieru; Franck Madoux; Eric Bishop; Jacob Beer; Louis Scampavia; Timothy Spicer
Journal:  Assay Drug Dev Technol       Date:  2015-12-15       Impact factor: 1.738

2.  Evidence for multiple forms of type I chromosomal beta-lactamase in Pseudomonas aeruginosa.

Authors:  M L Gates; C C Sanders; R V Goering; W E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

Review 3.  Discovery and development of new antimicrobial agents.

Authors:  T D Gootz
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

4.  Differences in the resistant variants of Enterobacter cloacae selected by extended-spectrum cephalosporins.

Authors:  J C Fung-Tomc; E Gradelski; E Huczko; T J Dougherty; R E Kessler; D P Bonner
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

5.  Purification of a class C A-type beta-lactamase from a derepressed strain of Enterobacter cloacae. Comparison of the wild-type and mutant enzyme with those from strains P99, 208 and GN7471.

Authors:  M N Graham; T J Mantle
Journal:  Biochem J       Date:  1989-06-15       Impact factor: 3.857

Review 6.  Clinical importance of inducible beta-lactamases in gram-negative bacteria.

Authors:  C C Sanders; W E Sanders
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

7.  Increased amounts of a novel penicillin-binding protein in a strain of methicillin-resistant Staphylococcus aureus exposed to nafcillin.

Authors:  H F Chambers; B J Hartman; A Tomasz
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

8.  Development of resistance to cephalosporins in clinical strains of Citrobacter spp.

Authors:  T D Gootz; D B Jackson; J C Sherris
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

9.  Influence of clindamycin on derepression of beta-lactamases in Enterobacter spp. and Pseudomonas aeruginosa.

Authors:  C C Sanders; W E Sanders; R V Goering
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191

10.  Cefotiam susceptibility testing criteria.

Authors:  P C Fuchs; A L Barry; R N Jones; C Thornsberry
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.